Blawg Search - Law Blogs, Lawyer Blogs, Legal Blogs Directory & Search Engine

... decision affirming the district court's claim construction and summary judgment of noninfringement in Abbott Laboratories v. Sandoz, Inc., the Court of Appeals for the Federal Circuit took the opportunity to reconcile a long-standing conflict in its precedent. ... , the court expressly overruled its earlier panel decision in Scripps Clinic & Research Foundation v. Genentech, Inc. in favor or the contrary panel decision in Atlantic Thermoplastics Co. v. Faytex Corp.; the decision affirms the ...

... E. Noonan --The Court of Appeals for the Federal Circuit affirmed grant of a preliminary injunction in Abbott Laboratories v. Sandoz on October 21, and also affirmed the District Court's determination that the patents-in-suit were not rendered unenforceable by inequitable conduct during prosecution (although defendant Sandoz will be able to pursue this defense at trial). In coming to both conclusions, the majority decision illustrated nicely the appellate penchant (and ...

News from Alabama yesterday: Jurors ordered Sandoz Inc. pay the State Government of Alabama $78.4 million for causing the state Medicaid program to pay too much for prescription drugs from 1991 to 2005. Evidence at trial? The evidence included a company memo that said: "Go forward and take the position of a Roman legion, be greedy and take no prisoners." Source here.

... the PatentHawk blog focusses on the injunction standards enumerated in the case Abbott Labs v. Sandoz,2008 U.S. App. LEXIS 21880 , decided on Oct. 21, and arrives ... worked through, among other things, anticipation and obviousness defenses put forward by Sandoz, which analyses make for interesting reading. But, in terms of the panel vote, note Before ... , starting with the First Circuit, the court summarized the standard in Wine and Spirits Retailers, Inc. v. Rhode Island, 418 F.3d 36 (1st Cir. 2005): ...

... of patents within a corporate enterprise - Novartis Pharm. Corp. v. Teva Pharm. USA, Inc. (Property, intangible) US: How do you solve a problem like Sidewiki (FDA Law Blog) ... filed in response to Paragraph IV certification - Novartis AG et al. v. Apotex Inc. et al. (Patent Docs) Prandimet (Repaglinide and Metformin) - US: Patent infringement suit filed in response to Paragraph IV certification: Novo Nordisk Inc. et al. v. Sandoz Inc (Patent Docs) Roundup Ready soybean seed - US: Monsanto files ...

... May 24, 2007) (Coar, J.). Judge Coar denied defendant Sandoz, Inc.'s ("Sandoz") motion to stay the Court's preliminary injunction pending appeal ... claim construction and because of the Supreme Court's KSR decision. First, Sandoz argued that two different Federal Circuit panels had issued differing rulings ... opinion. Second, the Court held that the KSR decision did not change its analysis of Sandoz's likelihood of success on its obviousness argument. The Court provided a detailed explanation of KSR ...

... Sanofi's patent; More claim construction confusion: Sanofi-Aventis v Sandoz (Patent Docs) (Patents4Life) (GenericsWeb) Mircera (Erythropoietin) - US: CAFC affirms most ... Sanofi's patent; More claim construction confusion: Sanofi-Aventis v Sandoz (Patent Docs) (Patents4Life) (GenericsWeb) Femcon and Loestrin 24 FE (Norethindrone ... Docs) Precedex (Dexmedetomidine) - US: Hospira files patent infringement suits against Sandoz in response to Para IV challenge (Patent Docs) Renegal (Sevelamer) - US: Endo ...

... on Tuesday, February 12 for all 25-microgram-per-hour Duragesic and Sandoz fentanyl pain patches with expiration dates on or before December 2009. Read the AP ... Sold in the United States under the brand name Duragesic by PriCara and generically by Sandoz Inc., the recall includes all 25-microgram-per-hour patches with expiration ... patches were also sold in Canada under the Duragesic brand by Janssen-Ortho Inc.Ranbaxy Laboratories Ltd. All of the patches were manufactured by PriCara affiliate ALZA ...

... Amgen) (Patent Docs) Products Actoplus MET (Pioglitazone) - US: Takeda files patent infringement suit against Sandoz following Para IV challenge (Patent Docs) Cozaar (Losartan) - Netherlands: Netherlands Patent Office grants extension to ... mark infringement and unfair competition (Patent Docs) Nexium (Esomeprazole) - Denmark: AstraZeneca faces early generic Nexium from Sandoz in Denmark (GenericsWeb) Omnicef (Cefdinir) - US: Are product by process claims dead?: Abbott v Sandoz (Patent Baristas) ...

Abbott Labs. v. Sandoz, Inc., No. 07 C 1721, Slip op. (N.D. Ill. May 3, 2007) (Anderson, J.). Judge Anderson denied plaintiffs' motion for a preliminary injunction to prevent defendants Sandoz, Inc. ("Sandoz") and Teva Pharmaceutical Industries, Ltd. ("Teva") from selling a generic version of plaintiff ... a crystalline cefdinir, does not expire until December 4, 2011. Plaintiffs argued that Sandoz's and Teva's respective formulations of cefdinir (the "accused products"), which the parties ...